WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin NMAI Nuveen details multiasset income market positioning and capital allocation plans in its latest quarterly earnings report NNDM Nano shares gain modestly after posting negative EPS for its 2025 third quarter